These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 9291886)

  • 1. Release of Candida albicans yeast antigens upon interaction with human neutrophils in vitro.
    Ashley C; Morhart M; Rennie R; Ziola B
    J Med Microbiol; 1997 Sep; 46(9):747-55. PubMed ID: 9291886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Candida krusei with human neutrophils in vitro.
    Richardson MD; Donaldson F
    J Med Microbiol; 1994 Dec; 41(6):384-8. PubMed ID: 7966213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and antigenic characterization of mannoprotein constituents released from yeast and mycelial forms of Candida albicans.
    Torosantucci A; Gomez MJ; Bromuro C; Casalinuovo I; Cassone A
    J Med Vet Mycol; 1991; 29(6):361-72. PubMed ID: 1815028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 priming regulates multiple steps of the neutrophil-mediated anti-Candida albicans response by modulating TLR and dectin-1 signals.
    Le HT; Tran VG; Kim W; Kim J; Cho HR; Kwon B
    J Immunol; 2012 Jul; 189(1):287-95. PubMed ID: 22661085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation and cellular localisation of the immunodominant 47-Kda antigen of Candida albicans.
    Matthews R; Wells C; Burnie JP
    J Med Microbiol; 1988 Dec; 27(4):227-32. PubMed ID: 3058979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A crossreactivity at the immunoglobulin E level of the cell wall mannoproteins of Candida albicans with other pathogenic Candida and airborne yeast species.
    Kanbe T; Utsunomiya K; Ishiguro A
    Clin Exp Allergy; 1997 Dec; 27(12):1449-57. PubMed ID: 9433941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of fungal proteinase during phagocytosis of Candida albicans and Candida tropicalis.
    Borg M; Rüchel R
    J Med Vet Mycol; 1990; 28(1):3-14. PubMed ID: 2194017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective phagocytosis and killing of Candida albicans via targeting FcgammaRI (CD64) or FcalphaRI (CD89) on neutrophils.
    van Spriel AB; van den Herik-Oudijk IE; van Sorge NM; Vilé HA; van Strijp JA; van de Winkel JG
    J Infect Dis; 1999 Mar; 179(3):661-9. PubMed ID: 9952373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of galectin-3 in phagocytosis of Candida albicans and Candida parapsilosis by human neutrophils.
    Linden JR; Kunkel D; Laforce-Nesbitt SS; Bliss JM
    Cell Microbiol; 2013 Jul; 15(7):1127-42. PubMed ID: 23279221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell surface/plasma membrane antigen of Candida albicans.
    Li RK; Cutler JE
    J Gen Microbiol; 1991 Mar; 137(3):455-64. PubMed ID: 1709679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of the interaction of murine phagocytic cells with Candida albicans.
    Morrison RP; Cutler JE
    J Reticuloendothel Soc; 1981 Jan; 29(1):23-34. PubMed ID: 7009855
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of immunodominant antigens of Candida albicans in patients with superficial candidosis.
    Weller BI; Simmons PD; Ivanyi L
    Clin Immunol Immunopathol; 1990 Mar; 54(3):347-53. PubMed ID: 2406053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector function of leucocytes from susceptible and resistant mice against distinct isolates of Candida albicans.
    Hu Y; Farah CS; Ashman RB
    Immunol Cell Biol; 2006 Oct; 84(5):455-60. PubMed ID: 16869942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils.
    Richardson MD; Brownlie CE; Shankland GS
    J Med Vet Mycol; 1992; 30(6):433-41. PubMed ID: 1287162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an in vitro model for the multi-parametric quantification of the cellular interactions between Candida yeasts and phagocytes.
    Dementhon K; El-Kirat-Chatel S; Noël T
    PLoS One; 2012; 7(3):e32621. PubMed ID: 22479332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane attack complex formation on yeast as trigger of selective release of terminal complement proteins from human polymorphonuclear leukocytes.
    Lukasser-Vogl E; Gruber A; Lass-Flörl C; Eder A; Høgåsen AK; Morgan BP; Dierich MP; Würzner R
    FEMS Immunol Med Microbiol; 2000 May; 28(1):15-23. PubMed ID: 10767603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A second stimulus required for enhanced antifungal activity of human neutrophils in blood is provided by anaphylatoxin C5a.
    Hünniger K; Bieber K; Martin R; Lehnert T; Figge MT; Löffler J; Guo RF; Riedemann NC; Kurzai O
    J Immunol; 2015 Feb; 194(3):1199-210. PubMed ID: 25539819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils.
    Svobodová E; Staib P; Losse J; Hennicke F; Barz D; Józsi M
    J Immunol; 2012 Sep; 189(5):2502-11. PubMed ID: 22851712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin.
    Richardson MD; Smyth LA; Shankland GS
    FEMS Microbiol Immunol; 1991 Oct; 3(5):299-303. PubMed ID: 1797051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme immunoassays for invasive Candida infections: reactivity of somatic antigens of Candida albicans.
    Zöller L; Krämer I; Kappe R; Sonntag HG
    J Clin Microbiol; 1991 Sep; 29(9):1860-7. PubMed ID: 1774309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.